211 related articles for article (PubMed ID: 21866466)
41. Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis.
Agis H; Sotlar K; Valent P; Horny HP
Leuk Res; 2005 Oct; 29(10):1227-32. PubMed ID: 16111540
[TBL] [Abstract][Full Text] [Related]
42. KIT D816V mutation-positive cell fractions in lesional skin biopsies from adults with systemic mastocytosis.
Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB
Dermatology; 2013; 226(3):233-7. PubMed ID: 23774045
[TBL] [Abstract][Full Text] [Related]
43. Aggressive systemic mastocytosis complicated by protein-losing enteropathy.
Mickys U; Barakauskiene A; De Wolf-Peeters C; Geboes K; De Hertogh G
Dig Liver Dis; 2007 Jul; 39(7):693-7. PubMed ID: 16843741
[TBL] [Abstract][Full Text] [Related]
44. Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event.
Jawhar M; Schwaab J; Schnittger S; Sotlar K; Horny HP; Metzgeroth G; Müller N; Schneider S; Naumann N; Walz C; Haferlach T; Valent P; Hofmann WK; Cross NC; Fabarius A; Reiter A
Leukemia; 2015 May; 29(5):1115-22. PubMed ID: 25567135
[TBL] [Abstract][Full Text] [Related]
45. Hidden mastocytosis in acute myeloid leukemia with t(8;21)(q22;q22).
Johnson RC; Savage NM; Chiang T; Gotlib JR; Cherry AM; Arber DA; George TI
Am J Clin Pathol; 2013 Oct; 140(4):525-35. PubMed ID: 24045550
[TBL] [Abstract][Full Text] [Related]
46. Clinical and Molecular Diagnostic Evaluation of Systemic Mastocytosis in the South-Eastern Hungarian Population Between 2001-2013--A Single Centre Experience.
Marton I; Krenács L; Bagdi E; Bakos A; Demeter J; Borbényi Z
Pathol Oncol Res; 2016 Apr; 22(2):293-9. PubMed ID: 26545382
[TBL] [Abstract][Full Text] [Related]
47. Detection of c-kit point mutation Asp-816 --> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia.
Sotlar K; Fridrich C; Mall A; Jaussi R; Bültmann B; Valent P; Horny HP
Leuk Res; 2002 Nov; 26(11):979-84. PubMed ID: 12363464
[TBL] [Abstract][Full Text] [Related]
48. Histone deacetylase inhibitor SAHA mediates mast cell death and epigenetic silencing of constitutively active D816V KIT in systemic mastocytosis.
Lyberg K; Ali HA; Grootens J; Kjellander M; Tirfing M; Arock M; Hägglund H; Nilsson G; Ungerstedt J
Oncotarget; 2017 Feb; 8(6):9647-9659. PubMed ID: 28038453
[TBL] [Abstract][Full Text] [Related]
49. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
50. Mastocytosis - an update.
Amon U; Hartmann K; Horny HP; Nowak A
J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
[TBL] [Abstract][Full Text] [Related]
51. Splenic mastocytosis: report of two cases and detection of the transforming somatic C-KIT mutation D816V.
Wimazal F; Schwarzmeier J; Sotlar K; Simonitsch I; Sperr WR; Fritsche-Polanz R; Födinger M; Schubert J; Horny HP; Valent P
Leuk Lymphoma; 2004 Apr; 45(4):723-9. PubMed ID: 15160946
[TBL] [Abstract][Full Text] [Related]
52. ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.
Damaj G; Joris M; Chandesris O; Hanssens K; Soucie E; Canioni D; Kolb B; Durieu I; Gyan E; Livideanu C; Chèze S; Diouf M; Garidi R; Georgin-Lavialle S; Asnafi V; Lhermitte L; Lavigne C; Launay D; Arock M; Lortholary O; Dubreuil P; Hermine O
PLoS One; 2014; 9(1):e85362. PubMed ID: 24465546
[TBL] [Abstract][Full Text] [Related]
53. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.
Pardanani A; Tefferi A
Curr Opin Hematol; 2010 Mar; 17(2):125-32. PubMed ID: 20075725
[TBL] [Abstract][Full Text] [Related]
54. Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine.
Lim KH; Pardanani A; Butterfield JH; Li CY; Tefferi A
Am J Hematol; 2009 Dec; 84(12):790-4. PubMed ID: 19890907
[TBL] [Abstract][Full Text] [Related]
55. Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders.
Perbellini O; Zamò A; Colarossi S; Zampieri F; Zoppi F; Bonadonna P; Schena D; Artuso A; Martinelli G; Chilosi M; Pizzolo G; Zanotti R
Cytometry B Clin Cytom; 2011 Nov; 80(6):362-8. PubMed ID: 21656905
[TBL] [Abstract][Full Text] [Related]
56. Interest of interferon alpha in systemic mastocytosis. The French experience and review of the literature.
Simon J; Lortholary O; Caillat-Vigneron N; Raphaël M; Martin A; Brière J; Barète S; Hermine O; Casassus P;
Pathol Biol (Paris); 2004 Jun; 52(5):294-9. PubMed ID: 15217717
[TBL] [Abstract][Full Text] [Related]
57. The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients.
Won D; Chi HS; Shim H; Jang S; Park CJ; Lee JH
Leuk Res; 2013 Aug; 37(8):883-8. PubMed ID: 23683787
[TBL] [Abstract][Full Text] [Related]
58. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.
Taylor ML; Sehgal D; Raffeld M; Obiakor H; Akin C; Mage RG; Metcalfe DD
J Mol Diagn; 2004 Nov; 6(4):335-42. PubMed ID: 15507672
[TBL] [Abstract][Full Text] [Related]
59. Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease (SM-AHNMD) in an infant patient.
Kawakami T; Haga T; Soma Y; Nagae C; Kinoshita A
J Dermatol; 2014 Aug; 41(8):761-3. PubMed ID: 25099159
[No Abstract] [Full Text] [Related]
60. Clonality and molecular pathogenesis of mastocytosis.
Akin C
Acta Haematol; 2005; 114(1):61-9. PubMed ID: 15995326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
